MondegarAI
SUVRETTA CAPITAL MANAGEMENT, LLC

Q4 2024 · 13F-HR

SUVRETTA CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2025-02-14 · accession 0001172661-25-001039

$2.93B
Reported value
96
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G1110E107BHVNBIOHAVEN LTD$209.9M7.15%5,620,271CommonSOLE
78462F103SPYSPDR S&P 500 ETF TR$205.1M6.99%350,000PUTSOLE
03969K108ARQTARCUTIS BIOTHERAPEUTICS INC$158.8M5.41%11,399,138CommonSOLE
46116X101ITCIEURINTRA-CELLULAR THERAPIES INC$120.2M4.10%1,439,026CommonSOLE
52490G102LEGNLEGEND BIOTECH CORP$113.8M3.88%3,496,234CommonSOLE
08205P209BNTCBENITEC BIOPHARMA INC$113.2M3.86%8,960,009CommonSOLE
457669307INSMINSMED INC$111.3M3.79%1,611,561CommonSOLE
30303M102METAMETA PLATFORMS INC$99.7M3.40%170,338CommonSOLE
282559103ETNBGBP89BIO INC$79.8M2.72%10,202,696CommonSOLE
023135106AMZNAMAZON COM INC$77.1M2.63%351,281CommonSOLE
03769M106APOAPOLLO GLOBAL MGMT INC$76.7M2.61%464,140CommonSOLE
191216100KOCOCA COLA CO$70.8M2.41%1,137,853CommonSOLE
874039100TSMTAIWAN SEMICONDUCTOR MFG LTD$68.3M2.33%345,912CommonSOLE
88160R101TSLATESLA INC$66.1M2.25%163,630CommonSOLE
04272N102AVBPARRIVENT BIOPHARMA INC$59.8M2.04%2,246,000CommonSOLE
30233G209EYPTEYEPOINT PHARMACEUTICALS INC$50.5M1.72%6,783,091CommonSOLE
594918104MSFTMICROSOFT CORP$49.9M1.70%118,397CommonSOLE
90400D108RAREULTRAGENYX PHARMACEUTICAL IN$48.4M1.65%1,151,314CommonSOLE
855244109SBUXSTARBUCKS CORP$47.0M1.60%514,922CommonSOLE
14040H105COFCAPITAL ONE FINL CORP$44.9M1.53%251,642CommonSOLE
50127T109KURAKURA ONCOLOGY INC$44.2M1.51%5,076,448CommonSOLE
31488V107FERGFERGUSON ENTERPRISES INC$42.6M1.45%245,530CommonSOLE
38141G104GSGOLDMAN SACHS GROUP INC$42.5M1.45%74,198CommonSOLE
483497103KALVKALVISTA PHARMACEUTICALS INC$41.6M1.42%4,913,012CommonSOLE
007903107AMDADVANCED MICRO DEVICES INC$40.8M1.39%337,415CommonSOLE
G25508105CRHCRH PLC$40.4M1.38%436,394CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$38.0M1.30%75,198CommonSOLE
68389X105ORCLORACLE CORP$37.7M1.29%226,318CommonSOLE
N44445109IMTXIMMATICS N.V$36.0M1.23%5,065,277CommonSOLE
101137107BSXBOSTON SCIENTIFIC CORP$35.5M1.21%397,679CommonSOLE
369604301GEGE AEROSPACE$33.5M1.14%200,662CommonSOLE
77313F106RCKTROCKET PHARMACEUTICALS INC$32.3M1.10%2,566,951CommonSOLE
29479A108ERASERASCA INC$30.9M1.05%12,315,004CommonSOLE
580135101MCDMCDONALDS CORP$30.0M1.02%103,638CommonSOLE
92343V104VZVERIZON COMMUNICATIONS INC$29.5M1.01%738,414CommonSOLE
88322Q108TGTXTG THERAPEUTICS INC$29.5M1.01%980,000CALLSOLE
097023105BABOEING CO$27.5M0.94%155,197CommonSOLE
12769G100CZRCAESARS ENTERTAINMENT INC NE$25.8M0.88%772,412CommonSOLE
03753U106APLSUSDAPELLIS PHARMACEUTICALS INC$25.3M0.86%793,187CommonSOLE
23804L103DDOGDATADOG INC$25.2M0.86%176,450CommonSOLE
21217B100CTNMCONTINEUM THERAPEUTICS INC$25.2M0.86%1,720,000CommonSOLE
67066G104NVDANVIDIA CORPORATION$24.3M0.83%180,756CommonSOLE
G7S53R104PROKIDNEY CORP$20.9M0.71%12,341,266CommonSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$20.5M0.70%3,685,503CommonSOLE
478160104JNJJOHNSON & JOHNSON$20.2M0.69%139,986CommonSOLE
910047109UALUNITED AIRLS HLDGS INC$19.5M0.66%200,650CommonSOLE
09062X103BIIBBIOGEN INC$17.7M0.60%115,436CommonSOLE
25754A201DPZDOMINOS PIZZA INC$16.1M0.55%38,340CommonSOLE
359616109FULCFULCRUM THERAPEUTICS INC$15.7M0.53%3,338,466CommonSOLE
N44821101IFRXINFLARX NV$14.2M0.48%5,733,910CommonSOLE
869367102SUTRO BIOPHARMA INC$13.7M0.47%7,462,495CommonSOLE
22788C105CRWDCROWDSTRIKE HLDGS INC$12.3M0.42%36,093CommonSOLE
G9TY5A101ZURAZURA BIO LTD$12.2M0.41%4,860,939CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$10.9M0.37%1,563,798CommonSOLE
60853G106MOLNMOLECULAR PARTNERS AG$10.5M0.36%2,221,494CommonSOLE
254687106DISDISNEY WALT CO$10.5M0.36%94,580CommonSOLE
03969F109RCUSARCUS BIOSCIENCES INC$8.6M0.29%576,156CommonSOLE
697947109PVLAPALVELLA THERAPEUTICS INC NE$8.6M0.29%714,463CommonSOLE
09077V100BIOABIOAGE LABS INC$8.4M0.29%1,452,336CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$6.5M0.22%1,840,891CommonSOLE
80105N105SNYSANOFI$6.3M0.22%131,501CommonSOLE
36266G107GEHCGE HEALTHCARE TECHNOLOGIES I$5.9M0.20%75,000CommonSOLE
30063P105EXKEXACT SCIENCES CORP$5.3M0.18%94,100CommonSOLE
58933Y105MRKMERCK & CO INC$5.3M0.18%53,000CommonSOLE
49372L2092KZ0KEZAR LIFE SCIENCES INC$4.8M0.16%716,759CommonSOLE
713317105PEPGPEPGEN INC$4.5M0.15%1,174,321CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$4.1M0.14%7,900CommonSOLE
002824100ABTABBOTT LABS$3.8M0.13%33,520CommonSOLE
235851102DHRDANAHER CORPORATION$3.1M0.11%13,600CommonSOLE
28414H103ELANELANCO ANIMAL HEALTH INC$3.1M0.10%253,600CommonSOLE
03073E105CORCENCORA INC$2.8M0.10%12,488CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$2.7M0.09%5,200CommonSOLE
252131107DXCMDEXCOM INC$2.5M0.08%31,680CommonSOLE
592688105MTDMETTLER TOLEDO INTERNATIONAL$2.4M0.08%1,964CommonSOLE
803607100SRPTSAREPTA THERAPEUTICS INC$2.2M0.07%17,888CommonSOLE
110122108BMYBRISTOL-MYERS SQUIBB CO$1.9M0.07%33,800CommonSOLE
632307104NTRANATERA INC$1.6M0.05%10,100CommonSOLE
863667101SYKSTRYKER CORPORATION$1.6M0.05%4,360CommonSOLE
05352A100AVTRAVANTOR INC$1.5M0.05%71,850CommonSOLE
46266C105IQVIQVIA HLDGS INC$1.4M0.05%7,175CommonSOLE
G5960L103MDTMEDTRONIC PLC$1.4M0.05%17,460CommonSOLE
941848103WATWATERS CORP$1.2M0.04%3,150CommonSOLE
58155Q103MCKMCKESSON CORP$1.0M0.04%1,830CommonSOLE
36315X101LKFTGALAPAGOS NV$1.0M0.03%37,111CommonSOLE
036752103ELVELEVANCE HEALTH INC$1.0M0.03%2,740CommonSOLE
40412C101HCAHCA HEALTHCARE INC$957,4790.03%3,190CommonSOLE
28176E108EWEDWARDS LIFESCIENCES CORP$821,7330.03%11,100CommonSOLE
00846U101AAGILENT TECHNOLOGIES INC$670,3570.02%4,990CommonSOLE
92338C103VLTOVERALTO CORP$557,6290.02%5,475CommonSOLE
761152107RMDRESMED INC$546,5690.02%2,390CommonSOLE
462222100IONSIONIS PHARMACEUTICALS INC$377,5680.01%10,800CommonSOLE
98956P102ZBHZIMMER BIOMET HOLDINGS INC$344,3540.01%3,260CommonSOLE
G8473T100STESTERIS PLC$314,5070.01%1,530CommonSOLE
69380Q107PACSPACS GROUP INC$262,2000.01%20,000CommonSOLE
071813109BAXBAXTER INTL INC$232,4050.01%7,970CommonSOLE
016255101ALGNALIGN TECHNOLOGY INC$229,3610.01%1,100CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.